GlassScriptPhysician profile
Kyle K Leong
NPI 1922169499
$2,749.72
in general payments reported to CMS, 2019-2025
12 companies · $1,185 in 2025
The $1,185 reported for 2025 was more than what 96% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27.19 · 2021: $473 · 2022: $195 · 2023: $566 · 2024: $304 · 2025: $1,185.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $943 · Travel and Lodging: $937 · Education: $95.34 · Gift: $78.76.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $943.22 |
| Travel and Lodging | $937.26 |
| Education | $95.34 |
| Gift | $78.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Henry Schein, INC. | $1,036.05 | 2022-2025 | Adec INC Newtron Slim 61 Kit, Dentrix Smart Image |
| Dentsply Sirona INC | $814.66 | 2021-2025 | Suresmile, Cavitron, Tph Spectra Universal Composite Restorative Low Viscosity |
| A-Dec, INC. | $174.57 | 2025 | |
| Patterson Companies, INC. | $143.03 | 2023-2025 | |
| Zimmer Biomet Holdings, INC. | $140.90 | 2021 | |
| Straumann USA LLC | $128.72 | 2023 | |
| Align Technology, INC. | $125.35 | 2022-2025 | Invisalign |
| Ivoclar Vivadent, INC. | $100.49 | 2023 | |
| Nobel Biocare USA | $27.19 | 2019 | |
| Zimvie INC. | $22.35 | 2024 | |
| Solventum Corporation | $21.62 | 2025 | V.A.C.Instill, Abthera |
| Colgate Oral Pharmaceuticals, INC. | $14.79 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Leong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.